Search details
1.
Low copy numbers of complement C4 and C4A deficiency are risk factors for myositis, its subgroups and autoantibodies.
Ann Rheum Dis
; 82(2): 235-245, 2023 Feb.
Article
in English
| MEDLINE | ID: mdl-36171069
2.
Anti-FHL1 autoantibodies in juvenile myositis are associated with anti-Ro52 autoantibodies but not with severe disease features.
Rheumatology (Oxford)
; 62(SI2): SI226-SI234, 2023 02 23.
Article
in English
| MEDLINE | ID: mdl-35961028
3.
Association of anti-HSC70 autoantibodies with cutaneous ulceration and severe disease in juvenile dermatomyositis.
Rheumatology (Oxford)
; 61(7): 2969-2977, 2022 07 06.
Article
in English
| MEDLINE | ID: mdl-34791087
4.
Anti-MDA5 autoantibodies associated with juvenile dermatomyositis constitute a distinct phenotype in North America.
Rheumatology (Oxford)
; 60(4): 1839-1849, 2021 04 06.
Article
in English
| MEDLINE | ID: mdl-33140079
5.
Corticosteroid discontinuation, complete clinical response and remission in juvenile dermatomyositis.
Rheumatology (Oxford)
; 60(5): 2134-2145, 2021 05 14.
Article
in English
| MEDLINE | ID: mdl-33067611
6.
Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis.
Ann Rheum Dis
; 78(7): 988-995, 2019 07.
Article
in English
| MEDLINE | ID: mdl-31018961
7.
Anti-NT5C1A autoantibodies are associated with more severe disease in patients with juvenile myositis.
Ann Rheum Dis
; 77(5): 714-719, 2018 05.
Article
in English
| MEDLINE | ID: mdl-29363513
8.
Features distinguishing clinically amyopathic juvenile dermatomyositis from juvenile dermatomyositis.
Rheumatology (Oxford)
; 57(11): 1956-1963, 2018 11 01.
Article
in English
| MEDLINE | ID: mdl-30016492
9.
Brief report: ultraviolet radiation exposure is associated with clinical and autoantibody phenotypes in juvenile myositis.
Arthritis Rheum
; 65(7): 1934-41, 2013 Jul.
Article
in English
| MEDLINE | ID: mdl-23658122
10.
Myositis-Associated Autoantibodies in Patients With Juvenile Myositis Are Associated With Refractory Disease and Mortality.
Arthritis Rheumatol
; 76(6): 963-972, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38272842
11.
Autoantibodies Recognizing Specificity Protein 4 Co-occur With Anti-Transcription Intermediary Factor 1 and Are Associated With Distinct Clinical Features and Immunogenetic Risk Factors in Juvenile Myositis.
Arthritis Rheumatol
; 75(9): 1668-1677, 2023 09.
Article
in English
| MEDLINE | ID: mdl-36996276
12.
Environmental factors associated with juvenile idiopathic inflammatory myopathy clinical and serologic phenotypes.
Pediatr Rheumatol Online J
; 20(1): 28, 2022 Apr 12.
Article
in English
| MEDLINE | ID: mdl-35414090
13.
Environmental factors preceding illness onset differ in phenotypes of the juvenile idiopathic inflammatory myopathies.
Rheumatology (Oxford)
; 49(12): 2381-90, 2010 Dec.
Article
in English
| MEDLINE | ID: mdl-20802007
14.
Long-term outcomes in Juvenile Myositis patients.
Semin Arthritis Rheum
; 50(1): 149-155, 2020 02.
Article
in English
| MEDLINE | ID: mdl-31303436
15.
Expression of interferon-regulated genes in juvenile dermatomyositis versus Mendelian autoinflammatory interferonopathies.
Arthritis Res Ther
; 22(1): 69, 2020 04 06.
Article
in English
| MEDLINE | ID: mdl-32252809
16.
Statin-induced anti-HMGCR myopathy: successful therapeutic strategies for corticosteroid-free remission in 55 patients.
Arthritis Res Ther
; 22(1): 5, 2020 01 08.
Article
in English
| MEDLINE | ID: mdl-31915059
17.
Immunoprecipitation-western blot for proteins of low abundance.
Methods Mol Biol
; 536: 259-75, 2009.
Article
in English
| MEDLINE | ID: mdl-19378065
18.
SDS-PAGE for 35S Immunoprecipitation and Immunoprecipitation Western Blotting.
Methods Mol Biol
; 1855: 417-436, 2019.
Article
in English
| MEDLINE | ID: mdl-30426436
19.
Predictors of acquired lipodystrophy in juvenile-onset dermatomyositis and a gradient of severity.
Medicine (Baltimore)
; 87(2): 70-86, 2008 Mar.
Article
in English
| MEDLINE | ID: mdl-18344805
20.
Autoantibodies and their significance in myositis.
Curr Rheumatol Rep
; 10(4): 333-40, 2008 Aug.
Article
in English
| MEDLINE | ID: mdl-18662515